Keyphrases
Cardiometabolic Risk
100%
Metabolic
100%
Semaglutide
100%
Risk Parameters
100%
Diabetes Risk
100%
Weight Loss
100%
Steatotic Liver Disease
100%
Randomized Controlled Trial
100%
Type 2 Diabetes Mellitus (T2DM)
100%
Weight Change
44%
Placebo
44%
Steatohepatitis
44%
Metabolic-associated Fatty Liver Disease (MAFLD)
33%
Diabetes Status
22%
Diabetes
22%
Randomized Trial
11%
Between-group
11%
Type 2 Diabetic Patients
11%
Fasting Plasma Glucose
11%
Insulin Level
11%
Treatment Difference
11%
Once-weekly
11%
Analysis of Covariance
11%
Glycated Hemoglobin
11%
Obesity
11%
Once-daily
11%
Risk Factors
11%
Spearman Rank Correlation
11%
Insulin Resistance
11%
Lipids
11%
Medicine and Dentistry
Cardiometabolic Risk
100%
Semaglutide
100%
Liver Disease
100%
Post-Hoc Analysis
100%
Diabetes
100%
Randomized Controlled Trial
100%
Maturity Onset Diabetes of the Young
100%
Steatohepatitis
57%
Placebo
57%
Carbetimer
14%
Analysis of Covariance
14%
Glycated Hemoglobin
14%
Patient with Type 2 Diabetes
14%
Insulin Resistance
14%
Nursing and Health Professions
Non Insulin Dependent Diabetes Mellitus
100%
Semaglutide
100%
Liver Disease
100%
Post Hoc Analysis
100%
Placebo
57%
Patient with Type 2 Diabetes
14%
Carbetimer
14%
Insulin Resistance
14%
Analysis of Covariance
14%
Insulin Level
14%
Glycosylated Hemoglobin
14%
Glucose Blood Level
14%